Pharmacopeia (Nasdaq: PCOP), an innovator in the discovery and development of novel small molecule therapeutics, announced the completion of recruitment in the company’s multi-center Phase 2a clinical study of PS433540 (DARA), the company’s lead internal product candidate.
More: continued here
Sciele Pharma, Inc. (NASDAQ:SCRX) and Addrenex Pharmaceuticals, Inc. announced that Addrenex has submitted a 505(b)(2) New Drug Application (NDA) to the Federal Food & Drug Administration (FDA) for CloniBID for the treatment of hypertension. Upon FDA approval, Sciele expects to launch this product in the first half of 2009.
More: continued here
Patients who prefer to be highly involved in their treatment don’t necessarily have better luck managing chronic health conditions, a new study suggests.A research team based at the Veterans Affairs (VA) Iowa City Health Care System and the University of Iowa surveyed 189 veterans with high blood pressure to determine the patients’ preferences for involvement in their health care.
More: continued here
Early and intensive lowering
More: continued here
Women who drank more fat free milk and had higher intakes of calcium and vitamin D from foods, and not supplements, tended to have a lower risk for developing hypertension or high blood pressure, according to a new study published in the American Heart Association journal, Hypertension.
More: continued here
Recordati announced the approval of Zan-Extra(R), a fixed combination of lercanidipine and enalapril indicated for the treatment of hypertension, in Australia. The Australian Register of Therapeutic Goods (ARTG) communicated its decision to approve the registration submitted by licensee Solvay Biosciences of Zan-ExtraŽ in its two dosage forms containing lercanidipine 10mg/enalapril 10mg and lercanidipine 10mg/enalapril 20mg.
More: continued here
King Pharmaceuticals, Inc. (NYSE: KG) announced the launch of its new ALTACE(R) Tablets (ramipril). King has received orders and initiated shipments of ALTACE(R) Tablets to many of its customers. The Company will continue to make available ALTACE(R) Capsules (ramipril). About ALTACE ALTACE is the leading branded ACE inhibitor with multiple indications. ALTACE is indicated for the treatment of hypertension.
More: continued here
Researchers from the University of Leeds’ Leeds Institute of Molecular Medicine recently said they are closer to developing a test that can predict preeclampsia, BBC News reports.
More: continued here
Is your heart healthy? It’s a good time to check because February is American Heart Month. Nearly 1 in 3 Americans has high blood pressure and many don’t even know it.* Left uncontrolled, the condition can have deadly consequences. Now, a new device is being tested to help people control their blood pressure using their body’s natural abilities. High blood pressure is the number one reason patients visit Dr.
More: continued here
Night-time noise from aircraft or traffic can increase a person’s blood pressure even if it does not wake them, according to a new study published today in the European Heart Journal.Scientists from Imperial College London and other European institutions monitored 140 sleeping volunteers in their homes near London Heathrow and three other major European airports.
More: continued here
